L C Ndhlovu

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease
    L C Ndhlovu
    Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, CA 94110, USA
    Clin Exp Immunol 158:294-9. 2009
  2. ncbi A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties
    Lishomwa C Ndhlovu
    Division of Experimental Medicine, Department of Medicine, University of California San Francisco, and HIV AIDS Division, San Francisco General Hospital, San Francisco, CA 94110, USA
    Eur J Immunol 40:134-41. 2010
  3. ncbi IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery
    Lishomwa C Ndhlovu
    Division of Experimental Medicine, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, USA
    J Clin Immunol 30:681-92. 2010
  4. ncbi HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications
    Lishomwa C Ndhlovu
    Division of Experimental Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America
    PLoS Negl Trop Dis 5:e1030. 2011

Detail Information

Publications4

  1. ncbi Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease
    L C Ndhlovu
    Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, CA 94110, USA
    Clin Exp Immunol 158:294-9. 2009
    ..These findings suggest that lower numbers of circulating NK T cells and enrichment of the CD4(+) NK T subset are associated with HTLV-1 disease progression...
  2. ncbi A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties
    Lishomwa C Ndhlovu
    Division of Experimental Medicine, Department of Medicine, University of California San Francisco, and HIV AIDS Division, San Francisco General Hospital, San Francisco, CA 94110, USA
    Eur J Immunol 40:134-41. 2010
    ..We propose that this novel CD4+ T-cell population counterbalances the suppressive activity of suppressor Treg in peripheral blood and serves as a calibrator of immunoregulation...
  3. ncbi IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery
    Lishomwa C Ndhlovu
    Division of Experimental Medicine, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, USA
    J Clin Immunol 30:681-92. 2010
    ..However, IL-2-mediated T-reg expansions may selectively reduce responses to certain antigen-specific populations, such as HIV-1 Gag...
  4. ncbi HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications
    Lishomwa C Ndhlovu
    Division of Experimental Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America
    PLoS Negl Trop Dis 5:e1030. 2011
    ....